
Pipramak TZ 4000mg/500mg Injection
Marketer
Maksun Biotech Pvt Ltd
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Pipramak TZ 4000mg/500mg Injection
Tazobactam/Piperacillin 4000mg/500mg injection is a dual-antibiotic formulation indicated for diverse bacterial infections. Its mechanism involves microbial eradication. Administration must be performed by a qualified medical practitioner; self-injection is strictly prohibited. Dosage and frequency are determined by your physician, based on your condition's severity. Adherence to prescribed usage is crucial. Commonly reported adverse effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin reactions (rash), and localized injection site responses (pain, swelling, erythema). Persistent or worsening side effects necessitate immediate medical consultation. Prior to treatment, disclose any antibiotic allergies, hepatic or renal impairments to your doctor; dose adjustments or alternative therapies may be necessary. While generally considered safe for pregnant and breastfeeding individuals under medical guidance, professional supervision is essential.
Uses of Pipramak TZ 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Pipramak TZ 4000mg/500mg Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strictly prohibited.
Common Side effects of Pipramak TZ 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Pipramak TZ 4000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Pipramak TZ 4000mg/500mg Injection works:
The injectable formulation Pipramak TZ (4000mg/500mg) merges piperacillin, a broad-spectrum antibiotic, with tazobactam, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam counteracts bacterial resistance mechanisms, thereby boosting piperacillin's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Pipramak TZ 4000mg/500mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Pipramak TZ (4000mg/500mg) is usually deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, research involving human subjects is scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Pipramak TZ (4000mg/500mg) is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer into breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Pipramak TZ 4000mg/500mg Injection on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCAUTION
The injectable formulation of Pipramak TZ (4000mg/500mg) requires careful administration in individuals with impaired renal function. Dosage modification for Pipramak TZ (4000mg/500mg) injection may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
For individuals with liver conditions, the use of Pipramak TZ 4000mg/500mg Injection appears to present minimal risk. Current evidence indicates dose modification might be unnecessary; however, medical advice is recommended.
What if you forget to take Pipramak TZ 4000mg/500mg Injection :
Should you inadvertently omit a dose of Pipramak TZ 4000mg/500mg Injection, seek medical advice from your physician.
Facts to Know About Pipramak TZ 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Infectious Disease Treatments |
